Semaglutide and Hair Loss: Is It the Weight Loss or the Drug?
It usually starts in the shower or on the hairbrush, a few months after the scale began to move. More hair than usual, coming out from all over the scalp. For a woman in midlife who may already be watching her hair thin, it is one of the more frightening things a weight-loss medication can seem to do.
The reassuring part is that, in most cases, the medication is not acting on the hair directly. The weight loss is. This page explains the difference, what the Wegovy label actually reports, what we check, and when the answer is a dermatologist rather than a wait. The main semaglutide page has the general picture.
What the label reports
Hair loss is listed in the prescribing information for branded Wegovy. In the label's pooled adult weight-reduction trials, hair loss was reported in 3% of people on Wegovy and 1% of people on placebo, over trials that ran for up to 68 weeks.
Those figures come from the Wegovy label and Novo Nordisk's trials of the branded product. They are not data on the compounded semaglutide ACT 2 prescribes. They are, though, the most careful count available, and they make two points worth holding onto. Hair loss is real and more common than on placebo. And it affects a small minority, not most people.
What the label does not do is say why. The trial counts record that hair loss happened, not whether the drug caused it or the weight loss did.
Telogen effluvium: shedding set off by a shock
Each hair on the scalp cycles between a long growing phase and a shorter resting phase, after which it falls out and a new hair starts. At any moment most hairs are growing.
A sudden stress on the body can push a large batch of growing hairs into the resting phase at once. A few months later they all fall out together. That is telogen effluvium, and the American Academy of Dermatology lists losing a substantial amount of weight among its common triggers, alongside childbirth, high fever, surgery and severe stress. The academy notes that shedding usually shows up a few months after the event and that, once the trigger has passed, hair tends to regain its normal fullness within six to nine months.
That timing is the clue. Shedding from rapid weight loss tends to appear two to three months into treatment, not in the first weeks. It is diffuse, from all over the scalp rather than in a patch or along a part line. And new hair is still growing; the follicles have not stopped working.
A 2026 systematic review of GLP-1 medications and hair loss, from dermatologists at Toronto and UCSF, found that telogen effluvium and pattern hair loss were the two types most often reported. It linked hair loss to the size and speed of weight loss, noted that women may be more susceptible, and found no strong evidence of permanent damage to the follicles.
Could the drug itself be doing it?
It is a fair question, and the honest answer is that nobody knows yet.
Reports of hair loss in the FDA's adverse event reporting system have risen with GLP-1 use, and a 2025 review in the Journal of Cosmetic Dermatology called the pattern biologically plausible. The same review was clear that a reporting system cannot establish cause. GLP-1 receptors have been found near hair follicles in mouse skin, and whether that applies in people is unknown.
What the evidence does support is this: the medications that produce the fastest and largest weight loss are the ones most often linked to shedding. That points to the weight loss as the main driver. It also fits the fact that dermatology references list weight loss and unusual diets among the ordinary triggers of shedding, with no GLP-1 involved.
One more thing the review points out. Telogen effluvium can unmask pattern hair loss that was already beginning. A woman in her fifties may notice, after the shedding settles, that her part is wider than it was. The GLP-1 did not cause that thinning, but the shedding brought it forward. Our page on shedding versus thinning explains how to tell the two apart.
What we check: ferritin, protein, thyroid
Shedding is usually self-limiting, but a few things can make it worse or keep it going. They are worth ruling out, and the 2026 review suggests the same short list.
Ferritin. Ferritin is the protein that stores iron, and iron deficiency is a recognized trigger for shedding, one that can be corrected. Eating less on a GLP-1 means taking in less iron, and women still having periods lose it every month. Our ferritin and hair loss page and the glossary entry explain what the test measures.
Protein. Hair is built from protein, and a smaller appetite can quietly cut protein intake well below what the body needs, especially if the meals that survive are the lighter ones. Protein also protects muscle during weight loss. The what to eat page covers how to keep it up when you are not hungry.
Thyroid. An underactive thyroid causes dry, thinning hair on its own, and MedlinePlus lists being a woman and being over 60 among the risk factors. Testing TSH separates a thyroid cause from a weight-loss cause. Our page on midlife or thyroid covers the overlap.
Vitamin D and a blood count are often added. The full baseline panel and what each marker tells the prescribing clinician is on the labs and monitoring page.
When to see a dermatologist
Most shedding on a GLP-1 does not need a specialist. Some does. The 2026 review suggests dermatology referral when hair loss:
- lasts longer than six to nine months
- follows a pattern, such as a widening part or thinning at the crown, or the hairs are getting finer
- comes with an itchy, red, scaly or painful scalp, which can point to a scarring type of hair loss
- leaves real doubt about what is going on
We would add round or oval bald patches, on the scalp or in the eyebrows or beard. The American Academy of Dermatology describes that patchy pattern as typical of alopecia areata, a different, autoimmune condition with different treatment.
A dermatologist can examine the scalp closely, sometimes take a small biopsy, and tell you whether you have shedding, thinning or both. If pattern hair loss is part of the picture, our hair loss treatment page covers the prescription options; whether one suits you is a separate clinical decision. In perimenopause, hormonal shifts add their own layer, which the page on perimenopause hair loss covers.
What to do in the meantime
Do not stop the medication on your own because of shedding. Talk to your prescribing clinician. If shedding is severe, weight is coming off very fast, or a deficiency is found, the plan may be revisited, and that is a decision made together.
Be gentle with the hair you have: avoid tight styles and harsh heat while it settles. Eat enough protein even when appetite is low. And give it time. Telogen effluvium is the one kind of hair loss where patience is usually the treatment.
Frequently asked questions
Hair loss is listed in the Wegovy label, reported in 3% of adults on Wegovy against 1% on placebo in its weight-reduction trials. Most of it appears to be telogen effluvium, shedding set off by rapid weight loss rather than a direct effect of the drug. Whether the drug adds anything of its own is not known.
Ozempic and Wegovy are branded semaglutide; the semaglutide ACT 2 prescribes is compounded, and it is not either brand. The mechanism people describe is the same: shedding a few months after weight starts coming off. The faster and larger the weight loss, the more likely it seems to be, whichever product is used.
Shedding from weight loss typically starts two to three months after the weight begins to fall, because that is how long resting hairs take to shed. The American Academy of Dermatology says hair usually regains its fullness within six to nine months once the trigger passes. Shedding beyond that deserves a closer look.
In telogen effluvium, yes, in most cases. The follicles are resting, not damaged, and a 2026 systematic review found no strong evidence of permanent follicle damage with GLP-1 medications. If the shedding uncovers pattern hair loss that was already starting, that part does not reverse on its own and needs its own assessment.
Only if a deficiency is found. Testing ferritin, thyroid and, often, vitamin D is more useful than guessing. Biotin supplements can interfere with some lab tests and produce incorrect results, which the FDA has warned about, so tell whoever orders your labs if you take one. Protein from food matters more than any supplement.
Not on your own. Most shedding settles as weight loss slows, and stopping does not bring hair back faster. Talk to your prescribing clinician, who may check ferritin and thyroid, look at how fast weight is coming off, and decide with you whether the plan needs to change.
Where this fits in your plan
If shedding is a worry before you start, a baseline panel with ferritin and thyroid gives a reference point to compare against later. The Semaglutide Injection page covers how the medication is used here, and the GLP-1 side effects FAQ covers the class as a whole.
We measure first. Then we act.
References
- U.S. Food and Drug Administration. WEGOVY (semaglutide) injection, prescribing information — section 6.1, Table 2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf
- Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Science Progress 2026;109. https://pmc.ncbi.nlm.nih.gov/articles/PMC13100445/
- Haykal D. Alopecia and semaglutide: connecting the dots for patient safety. Journal of Cosmetic Dermatology 2025;24:e70125. https://pmc.ncbi.nlm.nih.gov/articles/PMC11909624/
- American Academy of Dermatology. Do you have hair loss or hair shedding? https://www.aad.org/public/diseases/hair-loss/insider/shedding
- DermNet. Telogen effluvium. https://dermnetnz.org/topics/telogen-effluvium
- MedlinePlus, U.S. National Library of Medicine. Ferritin blood test. https://medlineplus.gov/lab-tests/ferritin-blood-test/
- MedlinePlus, U.S. National Library of Medicine. Hypothyroidism. https://medlineplus.gov/hypothyroidism.html
- American Academy of Dermatology. Alopecia areata: overview. https://www.aad.org/public/diseases/hair-loss/types/alopecia
- U.S. Food and Drug Administration. Biotin interference with troponin lab tests — assays subject to biotin interference. https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference
- Back toSemaglutide Injection
- Ferritin and hair lossLow ferritin is a genuine and correctable contributor to hair shedding — and the threshold that matters for hair is contested. What the evidence supports.Read
- Shedding versus thinningShedding and thinning are different problems with different causes and different outcomes. How to tell which one you have, and why it changes what to do.Read
- Perimenopause hair lossPerimenopause hair loss is usually pattern thinning unmasked as estrogen falls. Iron, thyroid, medications and stress shedding are checked first.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.